Document Detail


Postconditioning improves postischemic cardiac dysfunction independently of norepinephrine overflow after reperfusion in rat hearts: comparison with preconditioning.
MedLine Citation:
PMID:  19786893     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We investigated whether the cardioprotective effect of ischemic postconditioning (postC) against ischemia/reperfusion (I/R)-induced cardiac dysfunction is associated with the negative control of I/R-enhanced norepinephrine (NE) overflow, an aggravating factor of I/R injury, in comparison with the effects induced by ischemic preconditioning (preC). According to the Langendorff technique, isolated rat hearts were subjected to 40-minute global ischemia followed by 30-minute reperfusion. PostC, consisting of three cycles of 30-second reperfusion followed by 30-second ischemia at the end of the 40-minute ischemia, improved I/R-induced cardiac dysfunction. However, the potency of this postC-induced improvement was somewhat weaker than that produced by preC, consisting of three cycles of 5-minute ischemia followed by 5-minute reperfusion before 40-minute ischemia. The preC treatment markedly suppressed I/R-enhanced NE overflow, whereas postC had no apparent effect. A nonselective nitric oxide synthase inhibitor, N-nitro-L-arginine, almost completely abolished postC-induced cardiac protection without affecting NE overflow, whereas the effect of preC on I/R-induced cardiac dysfunction and NE overflow was only partially inhibited by N-nitro-L-arginine. These findings indicate that the beneficial effect of postC on I/R-induced cardiac dysfunction depends on nitric oxide and is irrelevant to NE overflow after reperfusion in contrast to the preC effect.
Authors:
Masashi Tawa; Taiki Fukumoto; Naoto Yamashita; Mamoru Ohkita; Kazuhide Ayajiki; Tomio Okamura; Yasuo Matsumura
Related Documents :
1696653 - Superoxide dismutase decreases reperfusion arrhythmias and preserves myocardial functio...
15103583 - New sialyl-lewis-x analogues antagonize leukocyte-induced ischemia-reperfusion arrhythm...
8960443 - The role of thrombolytic drugs in the management of myocardial infarction. comparative ...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  55     ISSN:  1533-4023     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2010-01-27     Completed Date:  2010-04-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  6-13     Citation Subset:  IM    
Affiliation:
Laboratory of Pathological and Molecular Pharmacology, Osaka University of Pharmaceutical Sciences, Osaka, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Ischemic Preconditioning / methods*
Male
Myocardial Reperfusion Injury / physiopathology,  prevention & control*
Nitric Oxide / metabolism*
Nitroarginine / pharmacology
Norepinephrine / metabolism*
Rats
Rats, Sprague-Dawley
Chemical
Reg. No./Substance:
10102-43-9/Nitric Oxide; 2149-70-4/Nitroarginine; 51-41-2/Norepinephrine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of effects of simvastatin versus atorvastatin on oxidative stress in patients with type 2...
Next Document:  Exposure-response relationship and risk assessment for cognitive deficits in early welding-induced m...